Yvet Noordman
Head of Pharmaceutical Development at LinXis Biopharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
LinXis Biopharmaceuticals
-
Netherlands
-
Biotechnology Research
-
1 - 100 Employee
-
Head of Pharmaceutical Development
-
Jan 2023 - Present
-
-
-
Kiadis Pharma
-
Netherlands
-
Biotechnology
-
1 - 100 Employee
-
Director Analytical development
-
Mar 2021 - Dec 2022
-
-
Principal Scientist Analytical Development
-
Jan 2020 - Feb 2021
-
-
Senior Scientist Analytical Development and Quality Control
-
May 2018 - Dec 2019
-
-
-
uniQure
-
Netherlands
-
Biotechnology Research
-
400 - 500 Employee
-
Senior Scientist Analytical Development/Team Lead Product Support
-
Jan 2014 - Apr 2018
o Supervision Scientists and Technicians Analytical Development, Product support groupo Method development, qualification and reporting of analytical packages supporting AAV-based product release testing o Reference standard qualificationo Master and Working Cell bank and Viral Seeds qualificationo Phase I/II product release and stability testing, support QP releaseo Setting product specificationso Extended product characterization (Phase I/II, Phase III and commercial products)o Product comparability (Phase I/II, Phase III and commercial products)o Assay validation according ICH Q2o Assay trouble shooting o Contribution to Module 3 of IND/IMPD and MAA dossierso Assay transfer to Quality Control department uniQure Lexington facilityo AD Lead Scientist in multi-disciplinary CMC project teams
-
-
Scientist Analytical Development
-
Nov 2010 - Dec 2013
o Responsible for the development of molecular biological assays (e.g. qPCR, PCR and gel based assays) o Setup assay validation strategies for Q-PCR methods according to ICH guidelineo Manage development of molecular biological assays at CRO o Additional (non-routine) characterization of rAAV products o Contribution to registration dossier (CMC section)o Manage assay transfer activities to Quality Control departmento Reference standards
-
-
Scientist Vector Development
-
Mar 2007 - Nov 2010
o Main focus to improve baculovirus-based rAAV production process using directed protein evolution and molecular biological approacheso rAAV product characterization using molecular biological and biochemical methodso Contribution to registration dossier (CMC section)
-
-
-
Radboudumc
-
Netherlands
-
Hospitals and Health Care
-
700 & Above Employee
-
Ph D student
-
Oct 2002 - Oct 2006
o Subject: Protein tyrosine phosphatase PTPRR isoforms function as multimeric brain-specific MAPK phosphatases o Techniques: Tissue culture, transfections, retroviral transduction, pull-down assays, co-immunoprecipitations, SDS-PAGE, quantitative Western blotting (Odyssey infrared imaging system), RT-PCR, PCR, cloning, site directed mutagenesis, RNA interference, immunohistochemistry, immunofluorescence and confocal laser scanning microscopy. o Subject: Protein tyrosine phosphatase PTPRR isoforms function as multimeric brain-specific MAPK phosphatases o Techniques: Tissue culture, transfections, retroviral transduction, pull-down assays, co-immunoprecipitations, SDS-PAGE, quantitative Western blotting (Odyssey infrared imaging system), RT-PCR, PCR, cloning, site directed mutagenesis, RNA interference, immunohistochemistry, immunofluorescence and confocal laser scanning microscopy.
-
-
Education
-
Radboud University
MSc, Chemistry -
Geert Groote College
Atheneum